Filing Details

Accession Number:
0001209191-16-157015
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-29 16:41:33
Reporting Period:
2016-12-27
Filing Date:
2016-12-29
Accepted Time:
2016-12-29 16:41:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1598646 Minerva Neurosciences Inc. NERV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405279 W Frederick Ahlholm C/O Minerva Neurosciences, Inc.
1601 Trapelo Road, Suite 284
Waltham MA 02451
Svp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-27 12,000 $4.71 22,000 No 4 M Direct
Common Stock Disposition 2016-12-27 17,000 $12.51 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2016-12-27 12,000 $0.00 12,000 $4.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
57,000 2025-12-03 No 4 M Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 - $13.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  3. This option vested as to 25% of the shares on December 4, 2016 and then in quarterly installments over 3 years thereafter.